Abstract
Since the first reports on chemokine function, much information has been generated on the implications of these molecules in numerous physiological and pathological processes, as well as on the signaling events activated through their binding to receptors. As is the case for other G protein-coupled receptors, chemokine receptors are not isolated entities that are activated following ligand binding; rather, they are found as dimers and/or higher order oligomers at the cell surface, even in the absence of ligands. These complexes form platforms that can be modified by receptor expression and ligand levels, indicating that they are dynamic structures. The analysis of the conformations adopted by these receptors at the membrane and their dynamics is thus crucial for a complete understanding of the function of the chemokines. We focus here on the methodology insights of new techniques, such as those based on resonance energy transfer for the analysis of chemokine receptor conformations in living cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702
Bachelerie F, Ben-Baruch A, Burkhardt AM et al (2013) International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 66:1–79
Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565–568
Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217–242
Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2:95–101
Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550
Baggiolini M, Dahinden CA (1994) CC chemokines in allergic inflammation. Immunol Today 15:127–133
Belperio JA, Keane MP, Arenberg DA et al (2000) CXC chemokines in angiogenesis. J Leukoc Biol 68:1–8
Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108–115
Godessart N, Kunkel SL (2001) Chemokines in autoimmune disease. Curr Opin Immunol 13:670–675
Proudfoot AE (2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2:106–115
Proudfoot AE, Handel TM, Johnson Z et al (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A 100:1885–1890
Jansma A, Handel TM, Hamel DJ (2009) Chapter 2. Homo- and hetero-oligomerization of chemokines. Methods Enzymol 461:31–50
Hamel DJ, Sielaff I, Proudfoot AE, Handel TM (2009) Chapter 4. Interactions of chemokines with glycosaminoglycans. Methods Enzymol 461:71–102
Salanga CL, Handel TM (2011) Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res 317:590–601
Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36–50
Seet BT, McFadden G (2002) Viral chemokine-binding proteins. J Leukoc Biol 72:24–34
Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116–122
De Paula VS, Gomes NS, Lima LG et al (2013) Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles. J Mol Biol 425:4479–4495
Chabre M, Deterre P, Antonny B (2009) The apparent cooperativity of some GPCRs does not necessarily imply dimerization. Trends Pharmacol Sci 30:182–187
Hernanz-Falcón P, Rodríguez-Frade JM, Serrano A et al (2004) Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 5:216–223
Rodríguez-Frade JM, Mellado M, Martínez-A C (2001) Chemokine receptor dimerization: two are better than one. Trends Immunol 22:612–617
Rodríguez-Frade JM, Vila-Coro AJ, de Ana AM et al (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci U S A 96:3628–3633
Thelen M, Muñoz LM, Rodríguez-Frade JM, Mellado M (2010) Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 10:38–43
Wu B, Chien EY, Mol CD et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330:1066–1071
Barroso R, Martínez Muñoz L, Barrondo S et al (2012) EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J 26:4841–4854
Pello OM, Martínez-Muñoz L, Parrillas V et al (2008) Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol 38:537–549
Martínez-Muñoz L, Barroso R, Dyrhaug SY et al (2014) CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface. Proc Natl Acad Sci U S A 111:E1960–E1969
Iiizumi M, Bandyopadhyay S, Watabe K (2007) Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. Cancer Res 67:1411–1414
Kumar A, Humphreys TD, Kremer KN et al (2006) CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 25:213–224
Herrera C, Morimoto C, Blanco J et al (2001) Comodulation of CXCR4 and CD26 in human lymphocytes. J Biol Chem 276:19532–19539
Yoshida T, Ebina H, Koyanagi Y (2009) N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol Immunol 53:629–635
Mellado M, Rodríguez-Frade JM, Vila-Coro AJ et al (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20:2497–2507
Rozenfeld R, Devi LA (2010) Receptor heteromerization and drug discovery. Trends Pharmacol Sci 31:124–130
Mellado M, Rodríguez-Frade JM, Vila-Coro AJ et al (1999) Chemokine control of HIV-1 infection. Nature 400:723–724
Molon B, Gri G, Bettella M et al (2005) T cell costimulation by chemokine receptors. Nat Immunol 6:465–471
Chen C, Li J, Bot G et al (2004) Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483:175–186
Szabo I, Wetzel MA, Zhang N et al (2003) Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 74:1074–1082
Rodríguez-Frade JM, Vila-Coro AJ, Martín A et al (1999) Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J Cell Biol 144:755–765
Percherancier Y, Berchiche YA, Slight I et al (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 280:9895–9903
Wilson S, Wilkinson G, Milligan G (2005) The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J Biol Chem 280:28663–28674
Harrison C, van der Graaf PH (2006) Current methods used to investigate G protein coupled receptor oligomerisation. J Pharmacol Toxicol Methods 54:26–35
Pfleger KD, Eidne KA (2006) Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3:165–174
Cardullo RA (2007) Theoretical principles and practical considerations for fluorescence resonance energy transfer microscopy. Methods Cell Biol 81:479–494
Boute N, Jockers R, Issad T (2002) The use of resonance energy transfer in high-throughput screening: BRET versus FRET. Trends Pharmacol Sci 23:351–354
Coulon V, Audet M, Homburger V et al (2008) Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer. Biophys J 94:1001–1009
Pfleger KD, Seeber RM, Eidne KA (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1:337–345
El-Asmar L, Springael JY, Ballet S et al (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67:460–469
Marullo S, Bouvier M (2007) Resonance energy transfer approaches in molecular pharmacology and beyond. Trends Pharmacol Sci 28:362–365
Dickinson ME, Bearman G, Tille S et al (2001) Multi-spectral imaging and linear unmixing add a whole new dimension to laser scanning fluorescence microscopy. Biotechniques 31:1272, 1274–1276, 1278
Zimmermann T, Rietdorf J, Girod A et al (2002) Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair. FEBS Lett 531:245–249
Mercier JF, Salahpour A, Angers S et al (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925–44931
Fuxe K, Ferré S, Canals M et al (2005) Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 26:209–220
Hu CD, Chinenov Y, Kerppola TK (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9:789–798
Hu CD, Kerppola TK (2003) Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 21:539–545
Kerppola TK (2006) Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol 7:449–456
Baíllo A, Martínez-Muñoz L, Mellado M (2013) Homogeneity tests for Michaelis-Menten curves with application to fluorescence resonance energy transfer data. J Biol Syst 21:1350017
Levoye A, Balabanian K, Baleux F et al (2009) CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:6085–6093
Martínez Muñoz L, Lucas P, Navarro G et al (2009) Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J Immunol 183:7337–7346
Motulsky H, Christopoulos A (2004) Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting. Oxford University Press, New York
Grinberg AV, Hu CD, Kerppola TK (2004) Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol Cell Biol 24:4294–4308
Acknowledgments
We specially thank the present and former members of the DIO chemokine group who contributed to some of the work described in this review. We also thank C. Bastos and C. Mark for secretarial support and editorial assistance, respectively. This work was partially supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF-2011-27270), the RETICS Program (RD 12/0009/009 RIER) and the Madrid regional government (S2010/BMD-2350; RAPHYME).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Martínez-Muñoz, L., Rodríguez-Frade, J.M., Mellado, M. (2016). Use of Resonance Energy Transfer Techniques for In Vivo Detection of Chemokine Receptor Oligomerization. In: Jin, T., Hereld, D. (eds) Chemotaxis. Methods in Molecular Biology, vol 1407. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3480-5_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3480-5_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3478-2
Online ISBN: 978-1-4939-3480-5
eBook Packages: Springer Protocols